Automated Anesthesia Delivery: The US Experience

Speakers

Image

Dr. David Hovord
Image

Dr. Arash Motamed

Watch the sponsored Symposium presented at ASA’s ANESTHESIOLOGY 2025 to learn more about the real-world impact of End-tidal Control.

The GE HealthCare sponsored Symposium focused on the US experience with End-tidal Control (Et Control)*. Available on the Aisys™ CS², Et Control software allows anesthesia providers to set targets for end-tidal oxygen and anesthetic agent. Et Control automatically adjusts fresh gas concentrations to quickly achieve and maintain those targets.

Key takeaways

Dr. Arash Motamed shares how Et Control drove a 75% reduction in gas flow, cutting costs and emissions at USC Keck offering insights into his journey of effectively engaging hospital leadership.
Dr. David Hovord reveals how automation to clinician-set targets drove patient safety, enhanced precision and efficiency across 140+ locations.

*Et Control is indicated for patients 18 years of age and older in the United States.

Disclaimer:

The statements made by the presenters are based on their own opinions on results that were achieved in their unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.

Refer to the anesthetic agent labeling for information regarding indications for use, warnings, and other relevant clinical information specific to that anesthetic agent. For example, labeling for sevoflurane includes specific warnings related to the potential risk associated with use at a low flow rate and under certain clinical conditions. Any decisions regarding selection of anesthetic agent and flow rate should be made at the discretion of the clinician and in their medical judgment based on available information.

GE is a trademark of General Electric Company used under trademark license. Reproduction in any form is forbidden without prior written permission from GE HealthCare. Nothing in this material should be used to diagnose or treat any disease or condition. Readers must consult a healthcare professional.

JB35686XX

Dr. David Hovord

University of Michigan

Dr. David Hovord is a Clinical Assistant Professor of Anesthesiology, specializing in Liver Transplant Anesthesiology. He is the Director of both Multispecialty Anesthesia and the Equipment and Supply Program. He also leads the Green Anesthesia Initiative at Michigan Medicine. Dr. Hovord is passionate about using technology to help improve patient safety in anesthesia and is a member of the Anesthesia Patient Safety Foundation Committee on Technology and the Patient Safety Committee at the University of Michigan. He gained his medical degrees from the Universities of Oxford and Cambridge in the United Kingdom.

Dr. Arash Motamed

Dr. Arash Motamed is an anesthesiologist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Keck Medical Center of USC and USC Norris Comprehensive Cancer Center. He received his medical degree from University of Southern California School of Medicine.